Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05124392 · ClinicalTrials.gov registry record
Biomarker Profiling in Individuals at Risk for Prion Disease
A clinical trial of CJD (Creutzfeldt Jakob Disease) and Prion Diseases, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05124392 is a study of CJD (Creutzfeldt Jakob Disease) and Prion Diseases that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05124392, a study of CJD (Creutzfeldt Jakob Disease) and Prion Diseases, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
We are doing this research to identify biomarkers in individuals who are at-risk for familial prion disease. We hope to use these biomarkers to predict timing of disease onset in pre-symptomatic individuals and to guide the direction of future clinical trials.
Conditions Studied
Study Locations (1)
Massachusetts
- Alzheimer's Clinical and Translational Research Unit - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2027-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05124392
The ClinicalTrials.gov registry entry for NCT05124392 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with CJD (Creutzfeldt Jakob Disease) appearing as the primary indexed condition, and to 0 interventions.
NCT05124392 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05124392 about?
NCT05124392 is a clinical study titled "Biomarker Profiling in Individuals at Risk for Prion Disease". We are doing this research to identify biomarkers in individuals who are at-risk for familial prion disease. We hope to use these biomarkers to predict timing of disease onset in pre-symptomatic individuals and to guide the direction of future clinical trials.
What is the current status of trial NCT05124392?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2017-12-01. Estimated completion is 2027-06-01.
What conditions does trial NCT05124392 study?
This clinical trial studies the following conditions: CJD (Creutzfeldt Jakob Disease), Prion Diseases, GSS, FFI, Familial Fatal Insomnia.
Who is sponsoring clinical trial NCT05124392?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05124392 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.